New Key Statistics Module, Z-Score and F-Score
NAS:JANX Key Ratios
| Market Cap $ M | 2,372.71 |
| Enterprise Value $ M | 1,738.11 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.61 |
| Price/Sales | 180.84 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 13.00 |
| EPS (TTM) $ | -1.16 |
| Beneish M-Score | -2.22 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -20.22 |
| EV-to-EBITDA | -20.72 |
| PEG | -- |
| Shares Outstanding M | 52.48 |
| Net Margin (%) | -463.91 |
| Operating Margin % | -658.76 |
| Pre-tax Margin (%) | -463.91 |
| Quick Ratio | 38.80 |
| Current Ratio | 38.80 |
| ROA % (ttm) | -10.65 |
| ROE % (ttm) | -11.37 |
| ROIC % (ttm) | -235.43 |
| Dividend Yield % | -- |
| Altman Z-Score | 37.00 |
JANX Number of Guru Trades
JANX Volume of Guru Trades
Gurus Latest Trades with NAS:JANX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:JANX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Janux Therapeutics Inc Insider Transactions
No Available Data
News about NAS:JANX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers